Published December 22, 2016
| Version v1
Patent
Open
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES
Contributors
Patent applicant:
Description
Antisense polynucleotides and their use in pharmaceutical compositions to induce exon skipping in targeted exons of the gamma sarcoglycan gene are provided, along with methods of preventing or treating dystrophic diseases such as Limb-Girdle Muscular Dystrophy.
Files
US20160369277.pdf
Files
(2.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:eb02d6d69cb4bddb4032fe951a8a93a7
|
2.0 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201615254817 A
- Patent number
- US 9777271 B2
- Other
- oai:uchicago.tind.io:7937
Dates
- Patent filed
-
2016-09-01